HomeStock ScreenerGenpharmasecQuarterly Results

Genpharmasec Quarterly Results for Trading Insights

Latest Quarter Net Profit
₹1 Cr
QMar 2026
Quarterly Results

In Mar 2026, Genpharmasec (GENPHARMA) reported revenue ₹57 Cr and net profit ₹1 Cr — revenue +280.0% YoY. View GENPHARMA annual price range for the annual high/low range and current price position.

GENPHARMA Quarterly Results — Revenue, Profit & EPS Highlights

Genpharmasec latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. Analyse GENPHARMA institutional holdings to track promoter, FII and institutional holdings.

  • Revenue of ₹57 Cr in Mar 2026 (+14.0% vs Jun 2026, +280.0% vs Mar 2025)
  • Net Profit of ₹1 Cr in Mar 2026
  • EBITDA of ₹3 Cr in Mar 2026 (+200.0% vs Jun 2026)
  • Operating Margin of 4.0% in Mar 2026 (+2.0pp vs Jun 2026)
  • Earnings Per Share of ₹0.02 in Mar 2026

Genpharmasec Quarterly Results — Revenue, EBITDA, Net Profit & EPS

GENPHARMA quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.

Metric Mar 2026 Jun 2026 Sept 2025 Mar 2025 Jun 2025 QoQ YoY
Revenue (₹ Cr) 57 50 33 15 13 14.0% 280.0%
Net Profit (₹ Cr) 1 0 -1 0 1 - -
EBITDA (₹ Cr) 3 1 0 0 2 - -
EPS (₹) 0.02 0.00 -0.02 -0.01 0.02 - -
Operating Margin (%) 4.0% 2.0% -1.0% -7.0% 8.0% - -

GENPHARMA Share Price Trend — 1-Year Movement Across Quarterly Results

Genpharmasec 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. For annual financials, live price and key ratios, visit GENPHARMA share price.

Profitability Ratios

Profit Margin 1.8%
EBITDA Margin 5.3%
Operating Margin 4.0%
ROE (Annual) 6.1%

Balance Sheet Highlights

Total Assets ₹138 Cr
Total Equity ₹66 Cr
Current Assets ₹81 Cr
Current Liabilities ₹26 Cr

Cash Flow Analysis

Operating Cash Flow ₹3 Cr
Investing Cash Flow ₹-15 Cr
Financing Cash Flow ₹-1 Cr
Net Cash Flow ₹-14 Cr

Current Market Data

Current Price ₹1.14
Exchange BSE
Last Updated Sep 18, 2026

GENPHARMA vs Commercial Services Peers — Quarterly Revenue, Profit & Market Cap

Genpharmasec latest quarter revenue and net profit vs Commercial Services competitors — market cap, price and earnings comparison.

Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Redington
Mar 2026
₹30,778.46 Cr 399.9 33,269 288 -4.9% - 0.9% 79.8
eClerx Services
Mar 2026
₹17,865.87 Cr 1915.6 1,137 190 -2.8% - 16.7% 93.6
Firstsource Solutio…
Mar 2026
₹17,257.49 Cr 273.5 2,611 205 -5.3% - 7.9% 92.1
International Gemol…
Mar 2026
₹13,530.92 Cr 331.0 387 180 +0.0% - 46.5% 79.6
WeWork India Manage…
Mar 2026
₹9,334.70 Cr 681.2 716 66 +2.1% - 9.2% 139.6
Sector Quarterly Performance Comparison
Commercial Services sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores